We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App





Olympus Highlights Surgical Visualization Platform for Future-Proof Endoscopic Surgery

By HospiMedica International staff writers
Posted on 31 Jan 2024

Olympus Corporation (Tokyo, Japan) is showing the latest innovations that redefine possibilities in healthcare, from state-of-the-art imaging technology to breakthrough medical procedures, at Arab Health 2024.

At the 49th edition of Arab Health, Olympus is showcasing, amongst others, its latest product launch, the VISERA ELITE III surgical visualization platform - an innovative and open solution that brings together multiple observation modes for future-proof endoscopic surgery. VISERA ELITE III offers various imaging functions, all supported in one system enabling minimally invasive therapies such as laparoscopic colectomy and laparoscopic cholecystectomy. By providing surgeons with multiple observation modes, the all-in-one system supports standardization and increases efficiency in the operating room. Users can also set up customized departmental profiles on VISERA ELITE III for different medical disciplines such as general surgery, urology, gynecology, ENT surgery, and more.

Olympus is also highlighting the POWERSEAL Sealer/Divider which supports the treatment of colon, stomach, lung, and other major types of cancer – but also non-cancer conditions – and can therefore be applied in various medical specialties, from lower to upper gastrointestinal surgery and gynecology, as well as in urology and other areas. Also being highlighted is the iTind, a non-surgical device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). The temporarily implanted nitinol device is inserted in an efficient and straightforward procedure with a short learning curve. Through gentle pressure on the tissue and localized ischemia, the iTind procedure aims to reshape the tissue of the prostatic urethra and the bladder neck. After 5-7 days, the iTind device is removed leaving nothing behind.

In addition, Olympus is showcasing the CELERIS disposable sinus debrider, a single-use microdebrider designed for ENTs who want the power and resection efficiency of a traditional sinus debrider in a convenient single-use solution, without compromising performance or quality. Within its medical portfolio, Olympus is showcasing its most advanced endoscopy system with AI, EVIS X1 which represents a range of new, easy-to-use technologies that aim to revolutionize the way gastrointestinal disorders can be detected, characterized, and treated.

Related Links:
Olympus Corporation

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Dual-Screen Medical Display
C822W
New
Medical Cart
Medical Carts
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Al-based NIHA-HF, standalone software detects heart failure using 30-second lead I ECG (Photo courtesy of Simplex Quantum)

Breakthrough AI Technology Accurately Assesses Heart Failure Severity

Heart failure (HF) is a complex condition where the heart cannot effectively pump blood to meet the body’s needs due to underlying medical issues. It is marked by recurring episodes and frequent hospitalizations.... Read more

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
ARAB HEALTH 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.